FEI 3002806982 of Farmak A.s. | GDUFA | Fees | Self Identification | PharmaCompass.com

Please Wait

Applying Filters...

FARMAK, A.s

FARMAK, a.s

VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

7 Corporate Content #SupplierSpotlight, 25 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

27 All APIs, 8 USDMF, 5 CEP/COS, 5 JDMF, 9 KDMF, 10 NDC API, 22 Listed APIs

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 6 Europe

KEY PRODUCTS

Alfuzosin Hydrochloride, Brimonidine Tartrate, Bromfenac Sodium, Dofetilide, Eszopiclone, Moxonidine, Regadenoson Monohydrate, Riluzole, Tafamidis, Tafamidis Meglumine, Tizanidine Hydrochloride, Zolpidem Tartrate

SERVICES

API Manufacturing, API & Drug Product Development

API Manufacturing
API & Drug Product Development
- 3 API Development

KEY SERVICES

GMP API Manufacturing, Kilolab & Small Scale API Manufacturing

INSPECTIONS & REGISTRATIONS

7 FDA, 17 EDQM, 1 GDUFA, 2 Others, 3 Third-Party Audit

Xls

Filters

Filters

FILTER :

filter Registrant Name Reset all filters

1 All

01 1Farmak A.S.

filter Facility Name Reset all filters

filter API Manufacture Reset all filters

List of Suppliers

Supplier Virtual Booth

price-trend

01

GDUFA fees paid

USA

The Benjamin Royal Sonesta

Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

Paid in : 2025

FARMAK, a.s

API Manufacturer : API MANUFACTURE

FDF Manufacturer :

Facility Name : Farmak A.S.

Business Address : NA VLCINCI 16/3 KLASTERNI HR...

FEI Number : 3002806982

Country : Czech Republic

Paid in : 2025

Farmak Company Banner

Product
Web Link

Stock Recap
#PipelineProspector

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.